Composition comprising lithospermum erythrorhizon extract for promoting hair growth and preventing or alleviating hair loss
The use of Lithospermum erythrorhizon extract in a composition addresses the limitations of existing hair loss treatments by promoting hair growth and preventing hair loss with increased dermal papilla cell proliferation and reduced side effects, offering a safer alternative for all demographics.
Patent Information
- Application Number
- PCT/KR2024/006106
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-08
- Filing Date
- 2024-05-07
- Publication Date
- 2024-11-14
AI Technical Summary
Current hair loss treatments, such as Propecia and minoxidil, have significant side effects and are limited in effectiveness and safety for women and children, necessitating the development of alternative hair growth agents with fewer side effects.
A composition containing Lithospermum erythrorhizon extract, which promotes hair growth by increasing dermal papilla cell proliferation and expression of cell proliferation markers, is used to prevent or improve hair loss.
The Lithospermum erythrorhizon extract composition effectively increases hair follicle number and size, reduces hair loss, and improves hair growth by enhancing markers like ERK, Akt, and β-catenin, with no reported side effects, making it a safer alternative for promoting hair growth and preventing hair loss.
Smart Images

Figure KR2024006106_14112024_PF_FP_ABST
Abstract
Description
Composition for promoting hair growth, preventing hair loss or improving hair loss, containing extract of rehmannia glutinosa
[0001] The present invention relates to a composition for promoting hair growth, preventing hair loss, or improving hair loss, which contains an extract of Rehmannia glutinosa as an active ingredient.
[0002]
[0003] Hair is very important not only because it primarily protects the skin and scalp, but also because it plays a unique role in social and sexual communication.
[0004] Hair is composed of the protein keratin and develops from hair follicles in the dermis. Scalp hair follicles are composed of dermal papilla cells, keratinocytes, inner and outer root sheath cells, and melanocytes. Among these, dermal papilla cells are a type of specialized fibroblast that form the basis of hair follicle development. Furthermore, dermal papilla cells are known to be closely related to hair growth.
[0005] Alopecia is the absence of hair in places where it would normally grow. Hair has no vital physiological function, but it plays a significant role in aesthetics. It also provides protection from UV rays and other functions.
[0006] As the hair loss market grows rapidly due to the increase in the number of people suffering from hair loss, products to prevent and treat hair loss are being developed, and the fundamental solution to hair loss treatment is to address the cause of hair loss.
[0007] Among the causes of hair loss, the most common type directly related to excessive secretion of androgens is androgenic alopecia, also known as male pattern baldness. A representative cause of male pattern baldness is dihydrotestosterone (DHT), which is produced by the enzyme 5-alpha reductase. Testosterone, one of the androgens, is converted to DHT by 5-alpha reductase, and the activated DHT binds to the androgen receptor, delaying protein synthesis in hair follicle cells and producing apoptotic factors such as BMP, DKK-1, and TGF-β, which inhibit Wnt / β-catenin signaling and induce hair loss.
[0008] Many studies have attempted to inhibit DHT synthesis, and a representative example is Propecia, a drug marketed by Merck Pharmaceuticals in the United States. Finasteride, the main ingredient in this drug, works by inhibiting the conversion of testosterone, a male hormone, to DHT. Propecia received FDA approval for use as a treatment for alopecia in 1997 and is currently on the market. However, its effects take several months to appear after administration, and it has minor side effects such as decreased libido and erectile dysfunction. Furthermore, it is only available to men, its safety in women and children has not been established, and it is prohibited for use by pregnant or potential pregnant women. Furthermore, minoxidil, developed by Pharmacia in the United States, is the most widely used drug for the treatment and prevention of alopecia. It is an FDA-approved hair loss treatment that promotes hair regrowth. Minoxidil is a topical medication that is somewhat effective in treating young, oily, and thinning hair, but in other cases, it only has a minimal effect, and side effects such as contact dermatitis, dry mouth, decreased blood pressure, and dizziness have been reported.
[0009] Due to the various side effects of conventional treatments, including Propecia and minoxidil, research into alternative hair growth agents is actively underway. However, no alternative has yet demonstrated superior scalp efficacy in clinical practice. Therefore, there is a pressing need to explore hair growth agents based on various natural substances and biomaterials, such as peptides, that offer superior efficacy and fewer side effects.
[0010] Against this backdrop, the inventors of the present invention have made diligent efforts to develop a natural material useful for hair promotion or hair loss prevention, and as a result, have confirmed that the extract of Ligusticum officinalis has hair growth efficacy and can be applied as a hair loss improvement material, thereby completing the present invention.
[0011]
[0012] The present invention aims to solve the above-mentioned problems and other problems related thereto.
[0013] An exemplary object of the present invention is to provide a food composition for promoting hair growth, preventing hair loss, or improving hair loss, which comprises an extract of Lithospermum erythrorhizon as an active ingredient.
[0014] Another exemplary object of the present invention is to provide a pharmaceutical composition for preventing or treating hair loss, comprising a rehmannia root extract as an active ingredient.
[0015] Another exemplary object of the present invention is to provide a health functional food for promoting hair growth, preventing hair loss, or improving hair loss, which contains a rehmannia root extract as an active ingredient.
[0016] Another exemplary object of the present invention is to provide a pharmaceutical composition for promoting hair growth, preventing hair loss, or improving hair loss, which comprises a rehmannia root extract as an active ingredient.
[0017] Another exemplary object of the present invention is to provide a feed composition for promoting hair growth, preventing hair loss, or improving hair loss, which comprises a rehmannia glutinosa extract as an active ingredient.
[0018] Another exemplary object of the present invention is to provide a cosmetic composition for promoting hair growth, preventing hair loss, or improving hair loss, which comprises a rehmannia root extract as an active ingredient.
[0019] Another exemplary object of the present invention is to provide a method for improving, preventing or treating hair loss, comprising a step of administering to a subject a composition comprising a rehmannia root extract as an active ingredient.
[0020] The technical problem to be achieved according to the technical idea of the invention disclosed in this specification is not limited to the problem to solve the above-mentioned problem, and other problems not mentioned will be clearly understood by those skilled in the art from the description below.
[0021]
[0022] This is explained in detail as follows. Meanwhile, each description and embodiment disclosed in this application can also be applied to each other description and embodiment. In other words, all combinations of the various elements disclosed in this application fall within the scope of this application. Furthermore, the scope of this application is not limited by the specific descriptions described below.
[0023] As one aspect for achieving the above object, the present invention provides a food composition for promoting hair growth, preventing hair loss, or improving hair loss, which comprises an extract of Lithospermum erythrorhizon as an active ingredient.
[0024] The term "Lithospermum erythrorhizon" in the present invention refers to a perennial herb of the Boraginaceae family, also called "jacho," "jichi," or "jageun," and is mainly distributed in East Asia, including Korea, Japan, and China. Lithospermum erythrorhizon is highly valuable as a raw material for Hongju (red wine) or as a dye, and has been reported in the private sector to have antibacterial and anti-inflammatory effects. However, its efficacy in promoting hair growth or improving hair loss has not been known to date.
[0025] In the present invention, the extract of the plant may be at least one extract selected from the group consisting of the whole plant, seeds, roots, flowers, and leaves of the plant, and may specifically be a root extract, but is not limited thereto.
[0026] In the present invention, the extract of Rehmannia glutinosa can promote the proliferation of mammary papilla cells and increase the expression of marker proteins associated with cell proliferation. The marker proteins may be, for example, ERK, Akt, GSK3β, or β-catenin, but are not limited thereto.
[0027] Specifically, in an embodiment of the present invention, it was confirmed that when human hair follicle dermal papilla cells (HFDPC) were treated with the extract of Rehmannia glutinosa, cell proliferation was promoted and the expression of cell proliferation-related markers ERK, Akt, GSK3β and β-catenin increased, and when the extract of Rehmannia glutinosa was administered to a mouse model, it was confirmed that the number and size of hair follicles increased in the skin tissue of the mouse, the expression of hair proliferation-related markers ERK, Akt and β-catenin increased, the expression of anti-apoptotic marker BCL-2 increased, and the expression of apoptotic marker BAX decreased.
[0028] In the present invention, the root may be used as is without damaging its original form, or may be used after performing a pretreatment process in consideration of the process speed and process (manufacturing) efficiency intended by a person skilled in the art, and the pretreatment process may include, for example, conventional steps such as selection, washing, cutting, powdering, and drying.
[0029] The term "hair growth promotion" of the present invention means not only the hair growth function of generating new hair or the function of enhancing hair growth, but also the function of promoting the delay from the growth phase to the regression phase and allowing existing hair to grow healthily.
[0030] The term "hair loss" in the present invention refers to a phenomenon in which hair falls out from the scalp or a phenomenon in which hair becomes thicker or thinner. Hair loss in the present invention may include androgenetic alopecia, telogen effluvium, anagen effluvium, alopecia areata, drug-induced telogen effluvium, postpartum telogen effluvium, etc. In addition, it may include all types of hair loss that form abnormal hair loss patterns, such as vellus hair, short hair in group hair, and atrophy of hair follicles, due to a series of factors.
[0031] The term "hair loss improvement" of the present invention refers to preventing hair loss from progressing and causing hair to grow, and includes improving a state in which hair is absent in areas where hair should normally exist due to various habits and environmental influences such as genetic causes, hormonal imbalance, mental stress from social life, exposure to air pollution, and consumption of processed foods.
[0032] In the present invention, the term "extract" includes the extract itself and all formulations that can be formed using the extract, such as an extract obtained by extraction treatment of the above-mentioned root, a diluted or concentrated extract, a dried product obtained by drying the extract, a controlled or purified product of the extract, or a mixture thereof.
[0033] In the present invention, the extraction is not particularly limited, and extraction can be performed according to a method commonly used in the relevant technical field. Non-limiting examples of the extraction method include hot water extraction, cold immersion extraction, solvent extraction, steam distillation, dissolution, compression, ultrasonic extraction, filtration, reflux extraction, etc., and these may be performed alone or in combination of two or more methods.
[0034] The extract of the present invention is obtained by extracting the root of the plant using an appropriate solvent, and may include, for example, a crude extract, a polar solvent-soluble extract, or a non-polar solvent-soluble extract. The type of extraction solvent used to prepare the extract is not particularly limited, and any solvent known in the art may be used. Non-limiting examples of the extraction solvent include water; alcohols having 1 to 4 carbon atoms, such as methanol, ethanol, propanol, isopropanol, butanol, propyl alcohol, and butyl alcohol; polyhydric alcohols, such as glycerin, butylene glycol, and propylene glycol; hydrocarbon solvents, such as methyl acetate, ethyl acetate, acetone, benzene, hexane, diethyl ether, and dichloromethane; or mixtures thereof. For example, the solvent may be selected from the group consisting of water, alcohols having 1 to 4 carbon atoms, or mixed solvents thereof.
[0035] The term "active ingredient" of the present invention means an ingredient that exhibits the desired activity alone or can exhibit the activity together with a carrier that is inactive in itself.
[0036] The term "comprising as an effective ingredient" of the present invention means including an effective amount capable of exhibiting the above-described hair growth promotion, hair loss prevention or improvement effect as a food composition.
[0037] The food composition of the present invention can be manufactured into various dosage forms, and unlike general drugs, it has the advantage of not having side effects that may occur when taking drugs for a long period of time by using food as a raw material. The food composition of the present invention can be manufactured into any form, and specifically, it can be one or more dosage forms selected from the group consisting of health functional food preparations such as tablets, capsules, pills, granules, liquids, powders, flakes, pastes, syrups, gels, jellies, bars, beverages, gums, and candies, but is not particularly limited thereto.
[0038] In addition, the food composition of the present invention may contain food additives in addition to the effective ingredients. Food additives can generally be understood as substances added to, mixed with, or infiltrated into food during the manufacturing, processing, or preservation of food, and their safety must be guaranteed because they are consumed daily and over a long period of time with food. The food additives are classified into sweeteners, flavoring agents, preservatives, emulsifiers, acidulants, thickeners, etc. in terms of function, and are not particularly limited as long as they are consistent with the purpose to be achieved by the food composition of the present invention. In addition, the food composition of the present invention may contain, in addition to the food additives, physiologically active substances or minerals known in the art for the purpose of functionality and nutritional supplementation and guaranteed for safety as food additives. The physiologically active substances or minerals are not particularly limited as long as they are consistent with the purpose to be achieved by the food composition of the present invention.
[0039] The food composition of the present invention may include the aforementioned food additives in an effective amount that can achieve the purpose of addition depending on the product type, and with respect to other food additives that may be included in the food composition of the present invention, reference may be made to the food codes or food additive codes of each country.
[0040] In another aspect of the present invention, the present invention provides a pharmaceutical composition for preventing or treating hair loss, comprising a rehmannia root extract as an active ingredient.
[0041] The terms “root”, “hair growth promotion”, “hair loss improvement” and “extract” of the present invention are as described above.
[0042] In the present invention, "prevention" means any action that inhibits or delays hair loss through administration of the pharmaceutical composition of the present invention, and "treatment" in the present invention means any action that improves, alleviates, or beneficially alters hair loss that has occurred through administration of the pharmaceutical composition of the present invention. In the present invention, "improvement" means any action that improves hair loss through administration of the composition.
[0043] In the present invention, the "pharmaceutical composition" means a composition manufactured for the purpose of preventing or treating a disease, and each can be formulated and used in various forms according to conventional methods. For example, it can be formulated in oral dosage forms such as powders, granules, tablets, capsules, suspensions, emulsions, syrups, etc., depending on the route of administration, and can be formulated and used in the form of topical preparations and sterile injectable solutions. Specifically, the administration route can be any appropriate route including topical route, oral route, intravenous route, intramuscular route, and direct absorption through mucosal tissue, and two or more routes can also be used in combination. An example of a combination of two or more routes is a case where two or more drug formulations are combined according to the route of administration, for example, a case where one drug is administered first via the intravenous route and another drug is administered secondarily via the topical route.
[0044] The pharmaceutical composition of the present invention may further comprise a pharmaceutically acceptable carrier, excipient, or diluent according to a conventional method. Pharmaceutically acceptable carriers are well known in the art depending on the route of administration or dosage form, and specific examples thereof may be found in the pharmacopoeias of each country, including the 'Korean Pharmacopoeia'. Carriers, excipients, and diluents that may be included in the composition of the present invention include, but are not limited to, lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol, maltitol, starch, acacia gum, alginate, gelatin, calcium phosphate, calcium silicate, cellulose, methyl cellulose, microcrystalline cellulose, polyvinyl pyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate, and mineral oil. Additionally, carriers, excipients, and diluents that may be included in the composition of the present invention may be non-natural carriers, but are not limited thereto.
[0045] The pharmaceutical composition of the present invention can be formulated and used in the form of oral dosage forms such as powders, granules, tablets, capsules, suspensions, emulsions, syrups, aerosols, etc., external preparations, suppositories, or sterile injection solutions according to conventional methods. Specifically, when formulating, it can be prepared using diluents or excipients such as fillers, bulking agents, binders, wetting agents, disintegrants, and surfactants that are commonly used. Solid preparations for oral administration include tablets, pills, powders, granules, capsules, etc., and such solid preparations can be prepared by mixing the above compound with at least one excipient, for example, starch, calcium carbonate, sucrose, lactose, gelatin, etc. In addition to simple excipients, lubricants such as magnesium stearate and talc can also be used. Liquid preparations for oral administration include suspensions, oral solutions, emulsions, and syrups. In addition to commonly used simple diluents such as water and liquid paraffin, various excipients such as wetting agents, sweeteners, flavoring agents, and preservatives may be included. Preparations for parenteral administration include sterile aqueous solutions, non-aqueous solvents, suspensions, emulsions, lyophilized preparations, and suppositories. Non-aqueous solvents and suspending agents may include propylene glycol, polyethylene glycol, vegetable oils such as olive oil, and injectable esters such as ethyl oleate. Suppository bases may include withepsol, macrogol, Tween 61, cacao butter, laurin butter, and glycerogelatin. Specific formulations of pharmaceutical compositions are known in the art, and reference may be made, for example, to Remington's Pharmaceutical Sciences (19th ed. 1995), which is incorporated herein by reference.
[0046] The pharmaceutical composition of the present invention is administered in a pharmaceutically effective amount. The pharmaceutically effective amount refers to an amount sufficient to treat a disease at a reasonable benefit / risk ratio applicable to medical treatment and not causing side effects. The effective dosage level may be determined based on factors including the patient's health condition, type and severity of the disease, drug activity and sensitivity to the drug, administration method, administration time, administration route and excretion rate, treatment period, combination or concurrent drug use, and other factors well known in the medical field. The dosage and frequency of administration do not limit the scope of the present invention in any way.
[0047] The pharmaceutical composition of the present invention can be administered to mammals, including rats, dogs, cats, cows, horses, pigs, and humans, via various routes, preferably to humans. Any route of administration is conceivable, including, but not limited to, oral, intravenous, intramuscular, or subcutaneous injection.
[0048] Another aspect of the present invention for achieving the above purpose provides a health functional food for promoting hair growth, preventing hair loss, or improving hair loss, comprising a rehmannia root extract as an active ingredient.
[0049] The terms “root”, “hair growth promotion”, “hair loss improvement” and “extract” of the present invention are as described above.
[0050] The term "health functional food" in the present invention refers to a food manufactured and processed using raw materials or ingredients with functionality beneficial to the human body. The term "functionality" refers to obtaining a beneficial effect for health purposes, such as regulating nutrients or physiological functions in relation to the structure and function of the human body. The health functional food of the present invention can be manufactured by methods commonly used in the art, and can be manufactured by adding raw materials and ingredients commonly added in the art during manufacturing.
[0051] In addition, the formulation of the above health functional food can be manufactured without limitation as long as it is a formulation recognized as a health functional food, and non-limiting examples of the formulation include one or more formulations selected from the group consisting of health functional food preparations such as tablets, capsules, pills, granules, liquids, powders, flakes, pastes, syrups, gels, jellies, bars, beverages, gums, and candies, but are not particularly limited thereto.
[0052] Another aspect of the present invention for achieving the above object provides a pharmaceutical composition for promoting hair growth, preventing hair loss, or improving hair loss, comprising an extract of Ligusticum japonica as an active ingredient.
[0053] The terms “root”, “hair growth promotion”, “hair loss improvement” and “extract” of the present invention are as described above.
[0054] The quasi-drug composition of the present invention may contain, in addition to the above-mentioned extract of the root of the plant, ingredients commonly used in quasi-drug compositions, and may include, but are not limited to, an abrasive, a humectant, a binder, a foaming agent, a sweetener, a preservative, a medicinal ingredient, a flavoring agent, a pigment, a solvent, a whitening agent, a solubilizer, or a pH adjuster.
[0055] In the present invention, the type of the above-mentioned quasi-drug is not particularly limited, and may be a quasi-drug commonly used in the relevant technical field. Non-limiting examples of the above-mentioned quasi-drug include one or more formulations selected from the group consisting of hair growth agents, scalp clinic agents, scalp scaling agents, scalp massage agents, scalp care agents, cleansers, shampoos, tonics, hair conditioners, hair lotions, gels, packs, creams, essences, powders, sprays, oils, soaps, ointments, hair styling agents, hair dyes, and perm agents. These may be used alone or in combination of two or more.
[0056] Another aspect of the present invention for achieving the above object provides a feed composition for promoting hair growth, preventing hair loss, or improving hair loss, comprising a rehmannia root extract as an effective ingredient.
[0057] The terms “root”, “hair growth promotion”, “hair loss improvement” and “extract” of the present invention are as described above.
[0058] In the present invention, the term "feed" may mean any natural or artificial diet, meal, etc. or a component of said meal, especially for eating, ingesting, and digesting by an animal or suitable therefor.
[0059] The type of the above feed is not particularly limited, and feed commonly used in the relevant technical field can be used. Non-limiting examples of the above feed include plant-based feed such as grains, roots, food processing by-products, algae, fiber, pharmaceutical by-products, oils, starches, meal, or grain by-products; and animal-based feed such as proteins, inorganic substances, oils, minerals, oils, single-cell proteins, zooplankton, or food. These may be used alone or in combination of two or more types.
[0060] Another aspect of the present invention for achieving the above object provides a cosmetic composition for promoting hair growth, preventing hair loss, or improving hair loss, comprising a rehmannia root extract as an active ingredient.
[0061] The terms “root”, “hair growth promotion”, “hair loss improvement” and “extract” of the present invention are as described above.
[0062] The above cosmetic composition may be formulated as a massage cream, powder, ointment, paste, gel, suspension, emulsion, spray, cosmetic liquid or capsule, but is not particularly limited thereto.
[0063] In addition, the cosmetic composition of the present invention may additionally include one or more cosmetically acceptable carriers that are incorporated into general skin cosmetics, and may appropriately incorporate conventional ingredients such as oil, water, surfactants, moisturizers, lower alcohols, thickeners, chelating agents, pigments, preservatives, fragrances, etc., but is not limited thereto. The cosmetically acceptable carriers included in the cosmetic composition of the present invention vary depending on the formulation.
[0064] When the formulation of the present invention is a solution or emulsion, a solvent, solubilizer or emulsifier is used as a carrier component, and examples thereof include water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1,3-butyl glycol oil, glycerol aliphatic ester, polyethylene glycol or fatty acid ester of sorbitan.
[0065] When the formulation of the present invention is a suspension, a liquid diluent such as water, ethanol or propylene glycol, a suspending agent such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, microcrystalline cellulose, aluminum metahydroxide, bentonite, or tragacanth may be used as a carrier component.
[0066] When the formulation of the present invention is an ointment, paste, cream or gel, animal oil, vegetable oil, wax, paraffin, starch, tragacanth, cellulose derivatives, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide may be used as a carrier component.
[0067] When the formulation of the present invention is a powder or spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component, and particularly in the case of a spray, a propellant such as chlorofluorohydrocarbon, propane / butane or dimethyl ether may be additionally included.
[0068] In addition, the cosmetic composition of the present invention may include, in addition to the extract of the root of the plant, commonly used auxiliary agents such as hydrophilic or lipophilic gelling agents, hydrophilic or lipophilic active agents, preservatives, antioxidants, solvents, fragrances, fillers, blocking agents, pigments, deodorants, and dyes.
[0069]
[0070] Another aspect of the present invention for achieving the above object provides a method for promoting hair growth; improving, preventing or treating hair loss, comprising administering to a subject a composition containing an extract of Lithospermum erythrorhizon as an active ingredient.
[0071] At this time, the terms “root”, “extract”, “hair growth promotion” and “hair loss improvement, prevention or treatment” of the present invention are as described above.
[0072] In the present invention, the above-mentioned extract of the root of the plant may be administered to a subject in need thereof in an amount effective for promoting hair growth; improving, preventing, or treating hair loss.
[0073] In the present invention, “effective amount” means an amount sufficient to achieve the effect of promoting hair growth; improving hair loss, preventing or treating the composition of the present invention described above.
[0074] The term "subject" as used herein includes, but is not limited to, a human, monkey, cow, horse, sheep, pig, chicken, turkey, quail, cat, dog, mouse, rat, rabbit or guinea pig, and preferably means a mammal, more preferably a human.
[0075] As used herein, the term “administration” means providing a given substance to a subject by any suitable means.
[0076] The composition of the present invention may be administered orally or parenterally via any conventional route as long as it can reach the target tissue. In addition, the composition of the present invention may be administered using any device capable of delivering the active ingredient to the target cell, tissue, or organ.
[0077] Another aspect of the present invention for achieving the above object provides a use of an extract of Lithospermum erythrorhizon for promoting hair growth, preventing hair loss, or improving hair loss.
[0078] Another aspect of the present invention for achieving the above object provides a use of an extract of Lithospermum erythrorhizon for the manufacture of a drug for improving, preventing or treating hair loss.
[0079] At this time, the terms “root”, “extract”, “hair growth promotion” and “hair loss improvement, prevention or treatment” of the present invention are as described above.
[0080]
[0081] The extract of the rehmannia glutinosa according to the present invention has no concerns about toxicity and has effects of promoting hair growth and preventing or improving hair loss. Therefore, food compositions, pharmaceutical compositions, health functional foods, quasi-drug compositions, feed compositions, and cosmetic compositions containing the extract of the rehmannia glutinosa as an active ingredient can be usefully used for promoting hair growth and preventing or improving hair loss.
[0082]
[0083] Figure 1 shows the extraction yield of the ethanol extract of the root of the plant.
[0084] Figure 2 shows the results of confirming the effect of ethanol extract of the root of the plant on promoting proliferation of mammary gland cells according to concentration.
[0085] Figure 3 shows the results confirming the increase in DNA synthesis in maternal papilla cells by treatment with the extract of the common chitosan plant.
[0086] Figure 4 shows the results confirming the increase in expression of marker proteins related to mammary papilla cell proliferation by treatment with the extract of the common chitosan plant.
[0087] Figure 5 shows the results of confirming the increase in immunofluorescence expression of β-catenin in hair papilla cells by treatment with the extract of the common rehmannia root.
[0088] Figure 6 shows the results of confirming the reduction in hair loss and hair loss area in mice administered with the extract of the root of the plant.
[0089] Figure 7 shows the results of confirming the increase in the number of hair follicles and hair follicle size in mice administered with the extract of the root of the plant.
[0090] Figure 8 shows the results of confirming the increase in expression of hair proliferation-related marker proteins in mouse skin tissue administered with the extract of the root of the plant.
[0091] Figure 9 shows the results of confirming an increase in the expression of an anti-apoptotic marker (BCL-2) and a decrease in the expression of an apoptotic marker (BAX) in mouse skin tissue administered with a rehmannia root extract.
[0092]
[0093] Hereinafter, the composition and effects of the present invention will be described in more detail through examples. These examples are intended solely to illustrate the present invention and are not intended to limit the scope of the present invention.
[0094]
[0095] Example 1: Preparation of Rehmannia glutinosa extract
[0096] The roots of Rehmannia glutinosa were extracted with 50%, 70%, and 100% ethanol (EtOH) at 80°C for 2 hours, concentrated, and freeze-dried to prepare ethanol extracts. The extraction yield was highest with 70% ethanol (Fig. 1), and the ethanol extract was then diluted with 100 mg / mL DMSO to make a stock. As a control, Rehmannia glutinosa was extracted with water at 80°C for 2 hours, concentrated, and freeze-dried to prepare a hot water extract.
[0097]
[0098] Example 2: In vitro analysis of the hair growth promotion efficacy of the extract of Rehmannia glutinosa
[0099] 2-1. Evaluation of mammary papilla cell proliferation
[0100] Human hair follicle dermal papilla cells (HFDPC cells, Cefobio, Korea) were cultured 4 times in DMEM medium containing 10% FBS and 1% PS, and then seeded in a 96-well plate at 1 x 10 HFDPC cells. 4 / well concentration, and the proliferation of hair papilla cells in the extract of the rehmannia glutinosa was evaluated through MTT assay (kit, Sigma-Aldrich) and BrdU (kit, Sigma-Aldrich) cell proliferation assay.
[0101] Specifically, for the MTT assay, the ethanol extract of Rehmannia glutinosa prepared in Example 1 was treated at concentrations of 0 (control), 12.5, 25, 50, 100, and 200 μg / mL in a 96-well plate seeded with hair follicle cells, and then reacted for 24 hours. Afterwards, 20 μL of a solution of the MTT reagent dissolved in PBS at a concentration of 5 mg / mL was added to each well, and the plate was reacted for 2 hours. After the reaction was completed, the medium and MTT solution were removed, and 200 μL of DMSO was added, shaken for 30 seconds, and the absorbance was measured at a wavelength of 570 nm.
[0102] As a result, no cytotoxicity was observed regardless of the concentration of the extract of Rehmannia glutinosa, and compared to the control group, proliferation of mammary papilla cells was confirmed at 132% in the 50% ethanol extract and 136% in the 70% ethanol extract (Fig. 2). On the other hand, the hot water extract of Rehmannia glutinosa showed no effect on mammary papilla cell proliferation.
[0103] In addition, to perform BrdU cell proliferation assay, 96-well plates seeded with dermal papilla cells were treated with 50% ethanol extract of Rehmannia glutinosa at concentrations of 6.25, 12.5, 25, 50, 100, and 200 μg / mL, respectively, and reacted for 24 hours. After that, the BrdU reaction solution was diluted to a 1X concentration in the medium, and 20 μL was treated for 16 hours. After removing the medium, the fixation solution (200 μL) was treated and reacted for 30 minutes at room temperature. After washing with washing solution, the plates were treated with BrdU detection antibody and reacted for 1 hour at room temperature. After washing again with washing solution, they were dried, treated with secondary antibody, and reacted for 30 minutes at room temperature. After washing, 100 μL of TMB substrate was treated, and reacted for 30 minutes in the dark. After that, the stop solution (100 μL) was treated and the absorbance was measured at a wavelength of 450 nm.
[0104] As a result, it was confirmed that DNA synthesis of mammary papilla cells significantly increased by treatment with 50% ethanol extract of Rehmannia glutinosa, regardless of treatment concentration (Fig. 3).
[0105]
[0106] 2-2. Evaluation of cell proliferation-related marker protein expression
[0107] We investigated whether the extract of Rehmannia glutinosa increases the expression of ERK, Akt, GSK3β, and β-catenin proteins, which are cell proliferation-related markers in hair papilla cells.
[0108] Specifically, 96-well plates seeded with dermal papilla cells were prepared in the same manner as in Example 2-1, and treated with 50% ethanol extract of Rehmannia glutinosa at concentrations of 0 (control), 50, and 100 μg / mL, respectively. Afterwards, proteins were extracted using Triton X lysis buffer (Thermo scientific, USA) according to the manufacturer's instructions, and centrifuged at 4°C and 3000 rpm for 10 minutes. The supernatant obtained by centrifugation was quantified using BCA protein assay (Thermo Scientific, USA), followed by electrophoresis on SDS-polyacrylamide gel, and the gel was transferred to a PVDF membrane (Trans-Blot, BioRad Laboratories). After that, the PVDF membrane was blocked with 5% skim milk, and the primary antibody was attached and left overnight at 4°C. After washing with 1X TBST, secondary antibodies were added and incubated at room temperature for 1 hour. After washing again with 1X TBST, ECL solution was added and the marker was detected.
[0109] As a result, in the group treated with the extract of Rehmannia glutinosa regardless of concentration to the papilla cells, the phosphorylation reactions of ERK, Akt, and GSK3β and the expression of β-catenin significantly increased compared to the control group, confirming that the ethanol extract of Rehmannia glutinosa increases the expression of marker proteins related to papilla cell proliferation (Fig. 4).
[0110]
[0111] 2-3. Immunofluorescence expression evaluation
[0112] We examined whether the fluorescence expression of β-catenin, which promotes the cell growth cycle, increased by treating the extract of Rehmannia glutinosa to the papilla cells.
[0113] Specifically, 96-well plates seeded with hair follicle cells were prepared in the same manner as in Example 2-1, and treated with 0 (negative control), 50, and 100 μg / mL concentrations of 50% ethanol extract of Rehmannia glutinosa and 1 μM minoxidil (positive control), respectively, and reacted for 24 hours. Afterwards, the plates were washed three times with PBS to remove the remaining medium and fixed with 4% paraformaldehyde. After washing again with PBS, 0.05% saponin was added and incubated at room temperature for 30 minutes. After washing three times, 1% BSA was added and incubated at room temperature for 1 hour. After washing again, the primary antibody was attached and incubated at 4°C overnight. After washing, the secondary antibody was attached and incubated at room temperature for 30 minutes. After washing again, DAPI was incubated at room temperature for 1 minute at 1:10000, washed, and the slides were thoroughly dried, covered with a cover glass, and immunofluorescence staining was completed, followed by observation under a fluorescence microscope.
[0114] As a result, it was confirmed that β-catenin, which promotes the cell growth cycle, moved into the nucleus by the treatment with the extract of the rehmannia root, and the green signal of β-catenin in the nucleus increased compared to the negative control group, and that the green signal in the rehmannia root extract treatment group also increased similarly compared to the minoxidil treatment group, which is the positive control group (Fig. 5).
[0115]
[0116] Example 3: In vivo analysis of the hair growth promotion efficacy of the extract of Rehmannia glutinosa
[0117] 3-1. Analysis of mouse hair growth efficacy
[0118] The hair growth promotion effect of the extract of the plant was investigated by administering it to a mouse model. The mouse model was B6CBAF1 / j female mice (6 weeks old), and eight mice were used per experimental group. A total of four experimental groups were prepared: i) negative control group (subcutaneous injection of 0.5 mg of testosterone (T) per day + oral administration of 100 μl of PBS (vehicle), ii) positive control group (subcutaneous injection of 0.5 mg of testosterone per day + oral administration of 0.5 mg / kg of finasteride per day), iii) experimental group 1 (subcutaneous injection of 0.5 mg of testosterone per day + oral administration of 100 μl (100 mg / kg) of 50% ethanol extract of Rehmannia glutinosa) per day), and iv) experimental group 2 (subcutaneous injection of 0.5 mg of testosterone per day + oral administration of 100 μl (200 mg / kg) of 50% ethanol extract of Rehmannia glutinosa) per day. The experiment was conducted for 16 weeks by subcutaneous injection and oral administration 5 times a week, hair photographs were taken once a week to check the degree of hair growth, and hair obtained from dissection was observed under a microscope.
[0119] As a result, it was confirmed that experimental groups 1 and 2 administered with the extract of the root of the plant showed less hair loss and a significant decrease in the hair loss area compared to the negative control group (Fig. 6).
[0120]
[0121] 3-2. Mouse skin tissue analysis
[0122] The skin tissues of the four groups prepared in Example 3-1 were stained with H&E to analyze the number and size of hair follicles.
[0123] Specifically, tissues fixed in 4% formaldehyde were made into paraffin blocks, then cut and mounted on slide glass. Paraffin was removed with xylene and xylene was removed with ethanol. Afterwards, the tissues were immersed in a hematoxylin solution to stain the nuclei, and the cytoplasm was counterstained with an eosin solution. After dehydration, the tissues were observed under a microscope.
[0124] As a result, it was confirmed that the number of hair follicles increased and the size of the hair follicles significantly increased in experimental groups 1 and 2 administered with the extract of the root of the plant compared to the negative control group (Fig. 7).
[0125]
[0126] 3-3. Analysis of hair proliferation-related marker protein expression in mouse skin tissue
[0127] The changes in the expression of hair proliferation-related marker proteins in mouse skin tissues by extracts of the plant were analyzed.
[0128] For the skin tissues of the four groups prepared in Example 3-1, proteins were extracted in the same manner as in Example 2-2, and the expression of ERK, AKT, and β-catenin related to hair proliferation was confirmed. As a result, it was confirmed that the phosphorylation reaction of ERK and AKT and the expression of β-catenin increased in experimental groups 1 and 2 administered with the extract of Rehmannia glutinosa compared to the negative control group (Fig. 8).
[0129] In addition, the expression of BCL-2, a marker related to anti-apoptotic cell death, and BAX, a marker related to pro-apoptotic cell death, was confirmed in the skin tissues of the four groups. As a result, it was confirmed that the expression of BCL-2 increased and the expression of BAX decreased in the group administered with the extract of the root ...
[0130]
[0131] From the above description, those skilled in the art will understand that the present invention can be implemented in other specific forms without altering its technical spirit or essential characteristics. In this regard, it should be understood that the embodiments described above are illustrative in all respects and not restrictive. The scope of the present invention should be interpreted as encompassing all changes or modifications derived from the meaning and scope of the following claims and their equivalent concepts, rather than the detailed description above.
Claims
1. A food composition for promoting hair growth, preventing hair loss, or improving hair loss, containing an extract of Lithospermum erythrorhizon as an active ingredient.
2. In paragraph 1, A food composition, wherein the extract is a crude extract obtained by extraction with a solvent selected from the group consisting of water, alcohols having 1 to 4 carbon atoms, or mixed solvents thereof.
3. In paragraph 1, A food composition wherein the composition promotes proliferation of breast papilla cells.
4. A pharmaceutical composition for preventing or treating hair loss, containing an extract of Rehmannia glutinosa as an active ingredient.
5. In paragraph 4, A pharmaceutical composition, wherein the extract is a crude extract obtained by extraction with a solvent selected from the group consisting of water, alcohols having 1 to 4 carbon atoms, or mixed solvents thereof.
6. A health functional food containing extracts of rehmannia glutinosa as an active ingredient for promoting hair growth, preventing hair loss, or improving hair loss.
7. In paragraph 6, The above health functional food is a health functional food in one or more dosage forms selected from the group consisting of health functional food preparations in the form of tablets, capsules, pills, granules, liquids, powders, flakes, pastes, syrups, gels, jellies, bars, beverages, gums, and candies.
8. A pharmaceutical composition for promoting hair growth, preventing hair loss, or improving hair loss, containing an extract of Rehmannia glutinosa as an active ingredient.
9. In paragraph 8, The above composition is a non-medical composition in the form of at least one formulation selected from the group consisting of a hair growth agent, a scalp clinic agent, a scalp scaling agent, a scalp massage agent, a scalp care agent, a cleanser, a shampoo, a tonic, a hair conditioner, a hair lotion, a gel, a pack, a cream, an essence, a powder, a spray, an oil, a soap, an ointment, a hair styling agent, a hair dye, and a perm agent.
10. A feed composition for promoting hair growth, preventing hair loss, or improving hair loss, containing an extract of rehmannia glutinosa as an active ingredient.
11. In paragraph 10, A feed composition, wherein the extract is a crude extract obtained by extraction with a solvent selected from the group consisting of water, alcohols having 1 to 4 carbon atoms, or mixed solvents thereof.
12. A cosmetic composition for promoting hair growth, preventing hair loss, or improving hair loss, containing an extract of Rehmannia glutinosa as an active ingredient.
13. In paragraph 12, A cosmetic composition, wherein the extract is a crude extract obtained by extraction with a solvent selected from the group consisting of water, alcohols having 1 to 4 carbon atoms, or mixed solvents thereof.
14. A method for improving, preventing or treating hair loss, comprising administering to a subject a composition containing an extract of Lithospermum erythrorhizon as an active ingredient.
Citation Information
Patent Citations
Hair cosmetic
JP1999343215A
Composition for preventing, improving or treating disorder associated with androgen receptor comprising extract of Lithospermi Radix as effective component
KR101876201B1
Pharmacy composition for enhancing Immunity containing Lithospermum erythrorhizon
KR1020080092008A
A composition for improving scalp and preventing hair loss containing an extract of Chinese medicine as an active ingredient
KR1020180092653A
KR20220153250A
